Studies in hyperkinetic behavior. II. Laboratory and clinical evaluations of drug treatments.
D000293:Adolescent; D000661:Amphetamine / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology* / Q000627:therapeutic use*; D000697:Central Nervous System Stimulants / Q000494:pharmacology* / Q000627:therapeutic use*; D002648:Child; D006613:Higher Nervous Activity / Q000187:drug effects*; D006801:Humans; D008124:Locomotion / Q000187:drug effects*; D008774:Methylphenidate / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D009069:Movement Disorders / Q000188:drug therapy*; D010634:Phenobarbital / Q000494:pharmacology / Q000627:therapeutic use; D010672:Phenytoin / Q000494:pharmacology / Q000627:therapeutic use
D000927:Anticonvulsants; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D010672:Phenytoin; D000661:Amphetamine; D010634:Phenobarbital